據報中車(01766.HK)獲智利國鐵歷來最大軌道車輛採購訂單
內媒報道,中國中車(01766.HK)獲智利國鐵歷來最大軌道車輛採購訂單。新購電動車組用於服務智利國家鐵路公司梅里皮亞-阿拉米達和巴圖科-金塔諾馬爾兩條鐵路線。
該訂單為「梅里皮亞和巴圖科」電動車組項目,於2021年啟動國際招標,中國中車旗下中車四方股份公司與Temoinsa智利公司組成的聯合體在國際招標中勝出。
電動車組預計在2025年開始交付。投入使用後,將提升智利國家鐵路的旅客運輸能力,使聖地亞哥到梅里皮亞地區的旅行時間縮短兩個小時,為沿線超過100萬居民提供更加便捷的交通出行方式。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.